MAPT and Cognitive impairment: In addition, vaccination with p-Ser422 Tau peptide against p-Ser422 Tau in mouse decreased the insoluble portion of Tau protein and improved cognitive deficits promoted by Tau pathology in a well-defined Tau transgenic model [26].